The Antenatal Corticosteroids Trial (ACT): a secondary analysis to explore site differences in a multi-country trial
BACKGROUND: The Antenatal Corticosteroid Trial (ACT) assessed the feasibility, effectiveness, and safety of a multifaceted intervention to increase the use of antenatal corticosteroids (ACS) in mothers at risk of preterm birth at all levels of care in low and middle-income countries. The intervention effectively increased the use of ACS but had no overall impact on neonatal mortality in the targeted
Citation
Klein, K., McClure, E., Colaci, D., Thorsten, V., Hibberd, PL., Esamai, F., ... Althabe, F. (2016). The Antenatal Corticosteroids Trial (ACT): a secondary analysis to explore site differences in a multi-country trial. Reproductive Health, 13, e64. DOI: 10.1186/s12978-016-0179-z
